KEAP1 and diabetes mellitus: UA-treated diabetic rats showed an accumulation of nuclear Nrf2 and increased expression of the keap1 protein in the hippocampus, indicating that UA activated a potent Nrf2-mediated adaptive response, which is impaired in diabetes.